Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3136)
All Articles published online
|
Feb 15, 2004 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bangoura G, Yang LY, Huang GW, Wang W. Expression of HIF-2α/EPAS1 in hepatocellular carcinoma. World J Gastroenterol 2004; 10(4): 525-530 [PMID: 14966910 DOI: 10.3748/wjg.v10.i4.525] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i4/525.htm |
| Number | Citing Articles |
| 1 |
Inho Choi, Saipriya Lammata, Neha Merchant, Dongkyoo Park. Role of Transcription Factors in Gastrointestinal Malignancies. 2017; : 465 doi: 10.1007/978-981-10-6728-0_35
|
| 2 |
Oleksandr H. Minchenko, Dariia O. Tsymbal, Dmytro O. Minchenko, Michel Moenner, Olena V. Kovalevska, Nadia M. Lypova. Inhibition of kinase and endoribonuclease activity of ERN1/IRE1α affects expression of proliferationrelated genes in U87 glioma cells. Endoplasmic Reticulum Stress in Diseases 2015; 2(1) doi: 10.1515/ersc-2015-0002
|
| 3 |
Cynthia Ju, Sean P. Colgan, Holger K. Eltzschig. Hypoxia-inducible factors as molecular targets for liver diseases. Journal of Molecular Medicine 2016; 94(6): 613 doi: 10.1007/s00109-016-1408-1
|
| 4 |
Bharath Nath, Gyongyi Szabo. Hypoxia and hypoxia inducible factors: Diverse roles in liver diseases. Hepatology 2012; 55(2): 622 doi: 10.1002/hep.25497
|
| 5 |
J Shen. Effects of arsenic trioxide on apoptosis and proliferation of human lung cancer cells under hypoxia. Journal of Chinese Integrative Medicine 2008; 6(3): 274 doi: 10.3736/jcim20080311
|
| 6 |
XINTING PAN, QINGYUN ZHU, YUNBO SUN, LIANDI LI, YUNPENG ZHU, ZHIHUI ZHAO, JIANXIN ZUO, WEI FANG, KUN LI. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo. International Journal of Molecular Medicine 2015; 35(4): 995 doi: 10.3892/ijmm.2015.2096
|
| 7 |
Xiaotian Dong, Xiaoru Su, Jiong Yu, Jingqi Liu, Xiaowei Shi, Qiaoling Pan, Jinfeng Yang, Jiajia Chen, Lanjuan Li, Hongcui Cao. Homology modeling and molecular dynamics simulation of the HIF2α degradation-related HIF2α-VHL complex. Journal of Molecular Graphics and Modelling 2017; 71: 116 doi: 10.1016/j.jmgm.2016.11.011
|
| 8 |
John Marentette, Cynthia Ju. Molecules, Systems and Signaling in Liver Injury. 2017; : 53 doi: 10.1007/978-3-319-58106-4_4
|
| 9 |
Changjun He, Xue‐Pu Sun, Haiquan Qiao, Xian Jiang, Dongdong Wang, Xiangguo Jin, Xuesong Dong, Jizhou Wang, Hongchi Jiang, Xueying Sun. Downregulating hypoxia‐inducible factor‐2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma. Cancer Science 2012; 103(3): 528 doi: 10.1111/j.1349-7006.2011.02177.x
|
| 10 |
Jie Guo, Tomohiko Akahoshi, Yukie Mizuta, Masaharu Murata, Sayoko Narahara, Takahito Kawano, Yoshihiro Nagao, Shuo Zhang, Morimasa Tomikawa, Hirofumi Kawanaka, Makoto Hashizume. Histidine‐Rich Glycoprotein Alleviates Liver Ischemia/Reperfusion Injury in Mice With Nonalcoholic Steatohepatitis. Liver Transplantation 2021; 27(6): 840 doi: 10.1002/lt.25960
|
| 11 |
Michele M. Hickey, M. Celeste Simon. . Current Topics in Developmental Biology 2006; 76: 217 doi: 10.1016/S0070-2153(06)76007-0
|
| 12 |
Min Ju Kim, Hyeyoun Chang, Gihoon Nam, Youngji Ko, Sun Hwa Kim, Thomas M. Roberts, Ju Hee Ryu. RNAi-Based Approaches for Pancreatic Cancer Therapy. Pharmaceutics 2021; 13(10): 1638 doi: 10.3390/pharmaceutics13101638
|
| 13 |
Mengzhen Li, Faren Xie, Lu Wang, Guoxue Zhu, Lian-Wen Qi, Shujun Jiang. Celastrol: An Update on Its Hepatoprotective Properties and the Linked Molecular Mechanisms. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.857956
|
| 14 |
Fei Luo, Baofei Sun, Huiqiao Li, Yuan Xu, Yi Liu, Xinlu Liu, Lu Lu, Jun Li, Qingling Wang, Shaofeng Wei, Le Shi, Xiaolin Lu, Qizhan Liu, Aihua Zhang. A MALAT1/HIF-2α feedback loop contributes to arsenite carcinogenesis. Oncotarget 2016; 7(5): 5769 doi: 10.18632/oncotarget.6806
|
| 15 |
M.Christiane Brahimi-Horn, Jacques Pouysségur. . International Review of Cytology 2004; 242: 157 doi: 10.1016/S0074-7696(04)42004-X
|
| 16 |
Joaquín Araos, Jonathan P. Sleeman, Boyan K. Garvalov. The role of hypoxic signalling in metastasis: towards translating knowledge of basic biology into novel anti-tumour strategies. Clinical & Experimental Metastasis 2018; 35(7): 563 doi: 10.1007/s10585-018-9930-x
|
| 17 |
Vincent Wai-Hin Yuen, Carmen Chak-Lui Wong. Hypoxia-inducible factors and innate immunity in liver cancer. Journal of Clinical Investigation 2020; 130(10): 5052 doi: 10.1172/JCI137553
|
| 18 |
Aki Pui-Wah Tse, Karen Man-Fong Sze, Queenie Tsung-Kwan Shea, Elley Yung-Tuen Chiu, Felice Ho-Ching Tsang, David Kung-Chun Chiu, Misty Shuo Zhang, Derek Lee, Iris Ming-Jing Xu, Cerise Yuen-Ki Chan, Hui-Yu Koh, Chun-Ming Wong, Yong-Ping Zheng, Irene Oi-Lin Ng, Carmen Chak-Lui Wong. Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer. Oncogenesis 2018; 7(5) doi: 10.1038/s41389-018-0052-8
|
| 19 |
Philip J. S. Charlesworth, Adrian L. Harris. Angiogenesis. 2008; : 169 doi: 10.1007/978-0-387-71518-6_15
|
| 20 |
Manqing Cao, Junrong Gao, Hongyuan Zhou, Jiafei Huang, Abin You, Zhigui Guo, Feng Fang, Wei Zhang, Tianqiang Song, Ti Zhang. HIF-2α regulates CDCP1 to promote PKCδ-mediated migration in hepatocellular carcinoma. Tumor Biology 2016; 37(2): 1651 doi: 10.1007/s13277-015-3527-7
|
| 21 |
Carolina Méndez-Blanco, Paula Fernández-Palanca, Flavia Fondevila, Javier González-Gallego, José L. Mauriz. Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: a systematic review with meta-analysis. Therapeutic Advances in Medical Oncology 2021; 13: 175883592098707 doi: 10.1177/1758835920987071
|
| 22 |
Alyssa Vito, Nader El-Sayes, Karen Mossman. Hypoxia-Driven Immune Escape in the Tumor Microenvironment. Cells 2020; 9(4): 992 doi: 10.3390/cells9040992
|
| 23 |
Lian-Yue Yang, Feng Fang, Di-Peng Ou, Wei Wu, Zhi-Jun Zeng, Fan Wu. Solitary Large Hepatocellular Carcinoma. Annals of Surgery 2009; 249(1): 118 doi: 10.1097/SLA.0b013e3181904988
|
| 24 |
Jung Hwa Lim, Dae-Ghon Kim, Dae-Yeul Yu, Hyun Mi Kang, Kyung Hee Noh, Dae-Soo Kim, Dongmin Park, Tae Kyung Chang, Dong-Soo Im, Cho-Rok Jung. Stabilization of E2-EPF UCP protein is implicated in hepatitis B virus-associated hepatocellular carcinoma progression. Cellular and Molecular Life Sciences 2019; 76(13): 2647 doi: 10.1007/s00018-019-03066-9
|
| 25 |
Hongjing Ma, Bin Liu, Shuoying Wang, Jing Liu. MicroRNA‐383 is a tumor suppressor in human lung cancer by targeting endothelial PAS domain‐containing protein 1. Cell Biochemistry and Function 2016; 34(8): 613 doi: 10.1002/cbf.3237
|
| 26 |
Xiaowei Zheng, Yiwen Zhang, Yujia Liu, Luo Fang, Li Li, Jiao Sun, Zongfu Pan, Wenxiu Xin, Ping Huang. HIF‐2α activated lncRNA NEAT1 promotes hepatocellular carcinoma cell invasion and metastasis by affecting the epithelial‐mesenchymal transition. Journal of Cellular Biochemistry 2018; 119(4): 3247 doi: 10.1002/jcb.26481
|
| 27 |
Ainiwaer Talifu, Refuhati Saimaiti, Yusufu Maitinuer, Geyu Liu, Miernisha Abudureyimu, Xuelei Xin. Multiomics analysis profile acute liver injury module clusters to compare the therapeutic efficacy of bifendate and muaddil sapra. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-40356-5
|
| 28 |
Yang Liu, Yawei Liu, Xiaolu Yan, Yuan Xu, Fei Luo, Jing Ye, Han Yan, Xiaojun Yang, Xiaodan Huang, Jianping Zhang, Guozhong Ji. HIFs enhance the migratory and neoplastic capacities of hepatocellular carcinoma cells by promoting EMT. Tumor Biology 2014; 35(8): 8103 doi: 10.1007/s13277-014-2056-0
|
| 29 |
S.-L. Yang, L.-P. Liu, J.-X. Jiang, Z.-F. Xiong, Q.-J. He, C. Wu. The Correlation of Expression Levels of HIF-1 and HIF-2 in Hepatocellular Carcinoma with Capsular Invasion, Portal Vein Tumor Thrombi and Patients' Clinical Outcome. Japanese Journal of Clinical Oncology 2014; 44(2): 159 doi: 10.1093/jjco/hyt194
|
| 30 |
Stefania Cannito, Umberto Dianzani, Maurizio Parola, Emanuele Albano, Salvatore Sutti. Inflammatory processes involved in NASH-related hepatocellular carcinoma. Bioscience Reports 2023; 43(1) doi: 10.1042/BSR20221271
|
| 31 |
Hye Jin Jung, Jong Hyeon Kim, Joong Sup Shim, Ho Jeong Kwon. A Novel Ca2+/Calmodulin Antagonist HBC Inhibits Angiogenesis and Down-regulates Hypoxia-inducible Factor. Journal of Biological Chemistry 2010; 285(33): 25867 doi: 10.1074/jbc.M110.135632
|
| 32 |
Chao Chen, Qianlei Yang, Dapeng Wang, Fei Luo, Xinlu Liu, Junchao Xue, Ping Yang, Hui Xu, Jiachun Lu, Aihua Zhang, Qizhan Liu. MicroRNA-191, regulated by HIF-2α, is involved in EMT and acquisition of a stem cell-like phenotype in arsenite-transformed human liver epithelial cells. Toxicology in Vitro 2018; 48: 128 doi: 10.1016/j.tiv.2017.12.016
|
| 33 |
Carmen Chak-Lui Wong, Alan Ka-Lun Kai, Irene Oi-Lin Ng. The impact of hypoxia in hepatocellular carcinoma metastasis. Frontiers of Medicine 2014; 8(1): 33 doi: 10.1007/s11684-013-0301-3
|